Intense 18F-PSMA-1007 Uptake of Splenic Hemangioma

被引：1
|
作者：
Jia, Guorong [1 ]
Dong, Aisheng [1 ]
Cheng, Chao [1 ]
Zuo, Changjing [1 ]
机构：
[1] Naval Med Univ, Dept Nucl Med, Affiliated Hosp 1, 168 Changhai Rd, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 02期
关键词：
spleen; hemangioma; PSMA; PET/CT; MEMBRANE ANTIGEN PET/CT;
D O I：
10.1097/RLU.0000000000004995
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 77-year-old man was referred for F-18-PSMA-1007 PET/CT scan for initial staging of biopsy-proved prostate adenocarcinoma. F-18-PSMA-1007 PET/CT showed focal intense F-18-PSMA-1007 of the prostate adenocarcinoma and a focal intense activity (SUVmax, 27) in the spleen. The F-18-PSMA-1007-avid splenic lesion corresponded to a splenic hemangioma, which was initially detected on contrast-enhanced CT 7 months ago and unchanged in size and enhancement pattern on follow-up contrast-enhanced CT. This case indicates that splenic hemangioma should be included in the differential diagnosis of PSMA-avid splenic lesions.
引用
收藏
页码：e90 / e92
页数：3
相关论文
共 50 条
  • [1] Skeletal 18F-PSMA-1007 uptake in prostate cancer patients
    Janssen, Jorinde
    Noordzij, Walter
    Velleman, Ton
    de Jong, Igle Jan
    Langendijk, Johannes A.
    Verzijlbergen, J. Fred
    Stormezand, Gilles N.
    Aluwini, Shafak
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [2] False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma
    Panagiotidis, Emmanouil
    Paschali, Anna
    Xourgia, Xanthi
    Chatzipavlidou, Vassiliki
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : 960 - 961
  • [3] Hemangioma of the Ilium Simulating Bone Metastasis on 18F-PSMA-1007 PET/CT
    Dong, Aisheng
    Nian, Shensheng
    Bai, Yushu
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e304 - e306
  • [4] 18F-PSMA-1007 Uptake Time: 90 vs 120 mins
    Sanderson, T.
    Stakhiv, O.
    Birchall, J.
    O'Dowd, S.
    O'Connor, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S498 - S498
  • [5] 18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" Sign
    Alfeeli, Mahamoud
    Marafi, Fahad
    Esmail, Abdulredha
    Fathallah, Wael M. A.
    Usmani, Sharjeel
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : 249 - 250
  • [6] Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT
    Geysen, Astrid
    Goffin, Karolien
    Van Weehaeghe, Donatienne
    Van Laere, Koen
    Deroose, Christophe M.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : E331 - E332
  • [7] Diffuse Intense 18F-PSMA-1007 Uptake of the Breasts in a Woman With TFE3-Rearranged Renal Cell Carcinoma
    Zhao, Qian
    Dong, Aisheng
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 693 - 694
  • [8] Equivocal Radiotracer Uptake on 18F-PSMA-1007 PET/CT in Patients with Prostate Cancer
    Spurr, M.
    Kimura, M.
    Kulshresthra, R.
    Kabala, J.
    Challapalli, A.
    Sakthithasan, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 42
  • [9] Increased Petrous Bone Uptake on 18F-PSMA-1007 PET/CT Due to Otospongiosis
    Neveu, Sophie
    Becker, Minerva
    Guinand, Nils
    Mainta, Ismini Charis
    Lenoir, Vincent
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (05) : 414 - 416
  • [10] Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET
    Arcay, Ayca
    Eiber, Matthias
    Langbein, Thomas
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 561 - 562
12345